Protean Biodiagnostics
Orlando, US · Founded 2017 · Florida corporation
Find your way into Protean Biodiagnostics
93 people in our graph share verified history with the Protean Biodiagnostics team — schools, employers, funds. One of them is your warm intro.
Dr. John L Evans Jrunlockedknows Anthony M. Magliocco · together at University of Central Florida (overlapped)
×4knows the team · via University of Alberta
×2knows the team · via University of Central Florida
×2knows the team · via The University of Lethbridge
×3knows the team · via Moffitt Cancer Center
Protean BioDiagnostics offers Protean MAPS, a cancer profiling and diagnostics platform that combines oncology tests with decision-support tools, telemedicine, virtual tumor boards, and AI-based clinical trial matching. It serves oncologists seeking precision oncology guidance across all cancer types.
Founders & leadership
Protean Biodiagnostics was founded in 2017 by Anthony M. Magliocco and Dr. Anthony Magliocco, MD FRCPC FCAP.
AM
Anthony M. MaglioccoinFounder and PresidentAnthony M. Magliocco is President and CEO of Protean Biodiagnostics, a precision oncology company offering cancer profiling and diagnostics tools. He brings expertise in pathology and focus on companion diagnostics and next-generation sequencing for oncology.
DA
Dr. Anthony Magliocco, MD FRCPC FCAPPresident and CEO; founder
Board
FM
Frank MorsaniBoard director
AC
Anees ChagparBoard director
Reported raises · per SEC filings
Form D private placements$1.8M disclosed across 2 of 4 rounds · 2019–2023
▶$6MofferedDec 2023 · Other Health CareRule 506(b)
▶$6MofferedDec 2023 · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ronen IsraelDirector
- Frank MorsaniDirector
- Susan LeeExecutive Officer
- Anees ChagparDirector
- Violet JamesonDirector
- Anthony Martin MaglioccoExecutive Officer, Director
- Offering amount
- $6M
- Minimum investment
- $50K
- Sales commissions
- $360K
- Proceeds to insiders
- $250K
- Placement agents
- Tangent Capital Partners, LLC
- Incorporated
- Corporation, Florida
- Federal exemptions
- 06b
▶$1.4MraisedMay 2021 · 12 investors · Other Health CareRule 506(b)
▶$1.4MraisedMay 2021 · 12 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Anees ChagparDirector
- Frank MorsaniDirector
- Anthony M. MaglioccoExecutive Officer, Director, Promoter
- Offering amount
- $1.7M
- Amount sold
- $1.4M
- Minimum investment
- $30K
- Incorporated
- Corporation, Florida, 2017
- Federal exemptions
- 06b
▶$1.5MofferedMay 2021 · Other Health CareRule 506(b)
▶$1.5MofferedMay 2021 · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Frank MorsaniDirector
- Anthony M. MaglioccoExecutive Officer, Director, Promoter
- Anees ChagparDirector
- Offering amount
- $1.5M
- Minimum investment
- $30K
- Placement agents
- Eastgate Securities, LLC
- Incorporated
- Corporation, Florida, 2017
- Federal exemptions
- 06b
▶$330KraisedJun 2019 · 4 investors · Other Health CareRule 506(b)
▶$330KraisedJun 2019 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Frank MorsaniDirector
- Anthony M. MaglioccoExecutive Officer, Director, Promoter
- Anees ChagparDirector
- Offering amount
- $800K
- Amount sold
- $330K
- First sale
- Jun 2019
- Incorporated
- Corporation, Florida, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlap
Labcorp8 shared keywordsLabCorp provides diagnostic testing services and clinical trial recruitment solutions that connect patient insights to drug development for healthcare providers.
Cancerresearchuk7 shared keywordsCancer Research UK funds research across discovery, detection, prevention and treatment of cancer to improve patient outcomes and extend survival. It operates as a research funder and scientific organization serving academic and clinical researchers.
MD Anderson Cancer Center7 shared keywordsUT MD Anderson is a cancer research and treatment center that provides patient care, conducts research, and offers education in cancer prevention and treatment. It is part of the University of Texas System and operates as a nonprofit medical institution.
Companies competing with Protean Biodiagnostics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Protean Biodiagnostics do?
- Protean BioDiagnostics offers Protean MAPS, a cancer profiling and diagnostics platform that combines oncology tests with decision-support tools, telemedicine, virtual tumor boards, and AI-based clinical trial matching. It serves oncologists seeking precision oncology guidance across all cancer types.
- Who founded Protean Biodiagnostics?
- Protean Biodiagnostics was founded by Anthony M. Magliocco, Dr. Anthony Magliocco, MD FRCPC FCAP in 2017.
- How much funding has Protean Biodiagnostics raised?
- Protean Biodiagnostics has disclosed $1.8M raised across 2 of its 4 known rounds.
- Where is Protean Biodiagnostics headquartered?
- Protean Biodiagnostics is headquartered in Orlando, US.